| 1 |
33703988 | Molecular docking and oxidation kinetics of 3-phenyl coumarin derivatives by human CYP2A13. | 2021 Nov |
5 |
| 2 |
31239454 | Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective. | 2019 Jun 25 |
1 |
| 3 |
29342418 | Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation. | 2018 Feb |
3 |
| 4 |
25547627 | Identification and functional characterization of novel feline cytochrome P450 2A. | 2015 |
1 |
| 5 |
23903410 | Mechanism-based inactivation of cytochrome P450 2A6 and 2A13 by Rhinacanthus nasutus constituents. | 2014 |
1 |
| 6 |
22696418 | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | 2012 Sep |
1 |
| 7 |
19251817 | Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes. | 2009 Jun |
3 |
| 8 |
17178771 | CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline. | 2007 Mar |
1 |
| 9 |
17922361 | Functional characterization of CYP2A13 polymorphisms. | 2007 Dec |
1 |
| 10 |
15196988 | Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation. | 2004 Jul 15 |
3 |
| 11 |
15333516 | Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. | 2004 Dec |
1 |
| 12 |
11016631 | Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. | 2000 Sep 15 |
1 |
| 13 |
7668294 | A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. | 1995 Sep |
1 |